NYU Abu Dhabi and RTW Investments Partner to Advance Healthcare Innovation in the Middle East
Strategic Collaboration to Convene Global Investors and Leaders for Healthcare Advancement Why is the Middle East emerging as a critical hub for healthcare innovation? NYU Abu Dhabi and RTW Investments, LP, are joining forces to address this question and more.…
Asahi Kasei Pharma Strengthens Drug Discovery Pipeline with Alchemedicine
Strategic License Agreement Advances Novel Compounds for Autoimmune Diseases Why are autoimmune diseases still a significant challenge for pharmaceutical companies? Asahi Kasei Pharma, a global leader in drug development, is taking a decisive step to address this issue. By entering…
Chemify and Sanacor Partner to Accelerate Mitochondrial Dysfunction Therapies
Chemify and Sanacor Join Forces to Tackle Diabetic Cardiovascular Disease Why is the discovery of new therapies for diabetic cardiovascular disease so critical? Chemify, a deep-tech pioneer in Chemputation, and Sanacor Inc., a biotechnology company focused on mitochondrial dysfunction, have…
Enveric Biosciences Secures Patent Protection Amidst Industry Challenges
Enveric Biosciences Overcomes Legal Hurdles to Protect Innovative Neuroplastogenic Therapeutics What does the withdrawal of a patent challenge mean for a biotech company’s intellectual property and future innovations? Enveric Biosciences a biotechnology company advancing novel neuroplastogenic small-molecule therapeutics for psychiatric…
BreezeBio Secures $60M Series B to Advance Genetic Medicines for Autoimmune Diseases
Funding Boosts Development of NanoGalaxy Platform and Lead Candidate BRZ-101 for Type 1 Diabetes Why is targeted gene delivery a critical challenge in the biotech industry? BreezeBio, a biotechnology company headquartered in South San Francisco, is addressing this issue with…
IQVIA Acquires Charles River Laboratories’ Discovery Services to Enhance Drug Discovery Capabilities
IQVIA Strengthens Early-Stage Discovery Research with Advanced In Vitro and AI-Driven Solutions Why is the life sciences industry facing a critical need for accelerated drug discovery? IQVIA Holdings Inc. a global leader in advanced analytics, technology solutions, and clinical research…
Sensei Biotherapeutics Grants Stock Options to 17 New Employees, Including COO
Strategic Move to Attract and Retain Talent in the Biotech Sector What does it take to attract top talent in the highly competitive biotech industry? Sensei Biotherapeutics, Inc. a clinical-stage biotechnology company focused on developing next-generation therapeutics for cancer patients,…
Mevion Medical Systems Receives CE Mark for World’s First LINAC Vault-Ready Proton Therapy System
Regulatory Milestone Enables European Expansion of Advanced Proton Therapy Why is proton therapy still out of reach for many European cancer centers? Mevion Medical Systems, the global leader in compact proton therapy, has announced that the MEVION S250-FIT Proton Therapy…
Ascensia Diabetes Care Appoints Peter Bodlund as CEO, Effective April 1, 2026
Leadership Transition Signals Ascensia’s Commitment to Long-Term Growth and Innovation Why is the leadership transition at Ascensia Diabetes Care significant for the global healthcare industry? Ascensia Diabetes Care, a global leader in diabetes management solutions, has announced the appointment of…
Ionis Pharmaceuticals Reports Strong 2025 Financials and Pipeline Progress
Ionis Poised for Continued Growth with Multiple Upcoming Therapeutic Launches Is the biotech industry ready for a new wave of transformative therapies? Ionis Pharmaceuticals, a leader in RNA-targeted therapies, reported robust financial results and significant pipeline advancements for the year ended…
Kivu Bioscience Advances KIVU-305 into Clinical Trials for CEACAM5-Expressing Cancers
Kivu Bioscience Secures HREC Approval and CTN Clearance for Next-Generation ADC Why are next-generation antibody-drug conjugates (ADCs) crucial for advancing cancer treatments? Kivu Bioscience, a clinical-stage biotechnology company based in San Mateo, CA, is making significant strides in this area.…
Epredia and Mindpeak Partner to Enhance Digital Pathology with AI
Epredia and Mindpeak Announce Distribution Agreement for AI-Based Image Recognition Software As cancer cases rise and diagnostic processes become more complex, pathology laboratories face increasing pressure to speed up processes and reduce costs. Epredia, a global leader in precision cancer…